相关实验视频

Updated: May 27, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

对人类核胺产生大鼠单克隆抗体

Yuki Nishino¹, Nao Ohshima¹, Tsukasa Osaki²

¹Department of Chemistry and Bioengineering, Graduate School of Engineering, Osaka Metropolitan University, Osaka, Japan.

Monoclonal antibodies in immunodiagnosis and immunotherapy

|February 20, 2025

概括

一种新的老鼠单克隆抗体 (mAb) 4H7识别了核胺 (NPM1),这是癌症中过度表达的蛋白质. 这种抗体对于分析NPM1功能和诊断癌细胞恶性转变非常有价值.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
免疫学免疫学免疫学

背景情况:

核胺 (NPM1) 对于核糖体生物发生,DNA修复和细胞周期调节至关重要.
NPM1在细胞区间之间穿,其改变的表达和定位与癌症恶性有关.
了解NPM1的作用对于癌症诊断和治疗至关重要.

研究的目的:

开发和表征一种新的鼠单克隆抗体 (mAb) 4H7,该抗体能够特别识别人类NPM1.
评估mAb 4H7在癌症细胞系中检测内源NPM1的实用性.
评估mAb 4H7对各种分子生物学应用的适用性.

主要方法:

鼠单克隆抗体 (mAb) 的发展 4H7.7.
免疫沉试验. 免疫沉试验.
免疫光染色. 免疫光染色.
免疫补充技术. 免疫补充技术.

主要成果:

mAb 4H7成功地在多个癌症细胞系中识别了内源人类NPM1.
该抗体证明适用于免疫沉,免疫光和免疫阻塞.
证实了mAb 4H7与NPM1的特定结合.

结论:

小说mAb 4H7是研究NPM1.7的宝贵工具.
这种抗体可以用于癌症研究中对NPM1的功能分析.
mAb 4H7具有通过NPM1表达和局部化试验来诊断恶性转变的潜力.

关键词:

人类癌症细胞系这是一种单克隆抗体.核的核心是核的核.核胺核胺是一种

更多相关视频

Generation of Monoclonal Antibodies Against Natural Products

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...